The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis

Journal of Clinical Immunology

Volumn 32, Issue 3, 2012, Pages 611-621

  Ferreyra Solari, Nazarena E ^a   Inzaugarat, María Eugenia ^a   Baz, Placida ^a   De Matteo, Elena ^b   Lezama, Carol ^b   Galoppo, Marcela ^b   Galoppo, Cristina ^b   Cherñavsky, Alejandra C ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Memory and naive T cell subsets; oxidative stress; pediatric NASH; polymorphonuclear cells; Th1 Th2 cytokines

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD45RA ANTIGEN; CD45RO ANTIGEN; CHOLESTEROL; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CELLULAR IMMUNITY; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOPHENOTYPING; INNATE IMMUNITY; LEUKOCYTE FUNCTION; LIVER BIOPSY; LIVER FIBROSIS; LYMPHOCYTIC INFILTRATION; MALE; MEMORY T LYMPHOCYTE; MICROENVIRONMENT; MONOCYTE; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; NONALCOHOLIC FATTY LIVER; PERIPHERAL LYMPHOCYTE; POLYMORPHONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH1 TH2 BALANCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; FATTY LIVER; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALE; NEUTROPHILS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER;

EID: 84861479460     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9635-2     Document Type: Article

References (43)

1. Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13:9-19.
2. Vuppalanchi R, Chalasani N. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: past, present and future directions. J Gastrointestin Liver Dis. 2010;19:415-23.
3. Brunt EM. Pathology of nonalcoholic steatohepatitis. Hepatol Res. 2005;33:68-71. (Pubitemid 41799777)
4. Brunt EM. Histopathology of non-alcoholic fatty liver disease. Clin Liver Dis. 2005;13:533-44.
5. Day C, James OFW. Steatohepatitis: a tale of two "hits"? Gastroenterology. 1998;114:842-5.
6. Basaranoglu M, Kayacetin S, Yilmaz N, Kayacetin E, Tarcin O, Sonsuz A. Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2010;16:2223-6.
7. Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology. 2004;40:820-6. (Pubitemid 39288114)
8. Jasen PML. Nonalcoholic steatohepatitis. J Med. 2004;62:217-24.
9. Pascale A, Pais R, Ratziu V. An overview of nonalcoholic steatohepatitis: past, present and future directions. J Gastrointestin Liver Dis. 2010;19:415-23.
10. Tominaga K, Fujimoto E, Suzuki K, Hayashi M, Ichikawa M, Inaba Y. Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. Environ Health Prev Med. 2009;14:142-9.
11. Argo CK, Caldwell SH. Epidemiology and natural history of nonalcoholic steatohepatitis. Clin Liver Dis. 2009;13:511-31.
12. Frith J, Jones D, Newton J. Chronic liver disease in an ageing population. Age Ageing. 2009;38:11-8.
13. Singh R, Bullard J, Kalra M, Assefa S, Kaul AK, Vonfeldt K, et al. Status of bacterial colonization, Toll like receptor expression and nuclear factor-kappa B activation in normal and diseased human livers. Clin Immunol. 2011;138:41-9.
14. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JÁ, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci. 2002;65:166-76. (Pubitemid 34121108)
15. Buffy G. Kupffer cells in non-alcoholic steatohepatitis: the emerging view. J Hepatol. 2009;51:212-23.
16. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol. 2002;37:56-62. (Pubitemid 34713055)
17. Abdelmalek MF, Diehl AM. Mechanisms underlying nonalcoholic steatohepatitis. Drug Discov Today: Dis Mech. 2006;3:479-88.
18. Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, Lavine JE. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42:641-9. (Pubitemid 41233657)
19. Rensen SS, Slaats S, Nijhuis J, Jans A, Bieghs V, Driessen A, Malle E, Greve JW, Buurman WA. Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am J Pathol. 2009;175:1473-82.
20. Adler M, Taylor S, Okebugwu K, Yee H, Fielding C, Fielding G, Poles M. Intrahepatic natural killer T cell populations are increased in human hepatic steatosis. World J Gastroenterol. 2011;17:1725-31.
21. Li QF, Li YP, Cheng PS. Peripheral T-lymphocyte subsets changes in patients with endocrine and metabolic diseases. Zhonghua Nei Ke Za Zhi. 1989;28:410-2.
22. Romo EM, Muñoz-Robles JA, Castillo-Rama M, Meneu JC, Moreno-Elola A, Perez-Saborido B, et al. Peripheral blood lymphocyte populations in end-stage liver diseases. J Clin Gastroenterol. 2007;41(7):713-21. (Pubitemid 47220478)
23. Inzaugarat ME, Ferreyra Solari NE, Billordo LA, Abecasis R, Gadano AC, Cherñavsky AC. Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis. J Clin Immunol. 2011;31:1120-30.
24. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp- Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-21. (Pubitemid 40770284)
25. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467-74. (Pubitemid 29420675)
26. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1-6.
27. De Basio MB, Periolo N, Avagnina A, Garcia de Davila MT, Ciocca M, Goñi J, de Mateeo E, Galoppo C, Cañero-Velasco MC, Fainboim H, Muñoz AE, Fainboim L, Cherñavsky AC. Liver infiltrating mononuclear cells in children with type 1 autoimmune hepatitis. J Clin Pathol. 2006;59:417-23.
28. Lalor PL, Shields P, et al. Recruitment of lymphocytes to the human liver. Immunol Cell Biol. 2002;80:52-64.
29. Lemmers A, Moreno C, Gustot T, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009;49:646-57.
30. Berard M, Tough DF. Qualitative differences between naïve and memory T cells. Immunology. 2002;106:127-38. (Pubitemid 34621821)
31. Linton JP, Haynes L, Tsui L, Zhang X, Swain S. From naive to effector - alterations with aging. Immunol Rev. 1997;160:9-18. (Pubitemid 28021362)
32. Kimmig S, Przybylski GK, Schmidt CA, Laurisch K, Mowes B, Radbruch A, Thiel A. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med. 2002;195:789-94. (Pubitemid 34259723)
33. - lymphocytes. Clin Exp Immunol. 1990;81:149-55.
34. Socha P, Michalkiewicz J, Stachowski J, Pawlowska J, Jankowska I, Barth C, Socha J, Madalinski K. Deficiency of the expression of CD45RA isoform of CD45 common leukocyte antigen in CD4+ T lymphocytes in children with infantile cholestasis. Immunol Let. 2001;78:179-84. (Pubitemid 32166772)
35. Summers KL, O'Donnell JL, Hart DNJ. Co-expression of the CD45RA and CD45RO antigens on T lymphocytes in chronic arthritis. Clin Exp Immunol. 1994;97:39-44. (Pubitemid 24244052)
36. Hu X, Gu Y, Wang Y, Cong Y, Qu X, Xu C. Increased CD4+ and CD8+ effector memory T cells in patients with aplastic anemia. Annu Rev Immunol. 2004;22:745-63.
37. Messi M, Giacchetto I, Nagata K, Lanzavecchia A, Natoli G, Saluusto F. Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol. 2003;4:78-86. (Pubitemid 36104711)
38. Weng HL, Cai WM, Liu RH. Animal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis. World J Gastroenterol. 2001;7:42-8. (Pubitemid 32170897)
39. Knight B, Lim R, Yeoh GC, Olynyk JK. Interferon-γ exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury. J Hepatol. 2007;47:826-33. (Pubitemid 350064325)
40. Videm V, Strand E. Changes in neutrophil surface-receptor expression after stimulation with FMLP endotoxin, interleukin-8 and activated complement compared to degranulation. Scand J Immunol. 2004;59:25-33. (Pubitemid 38186836)
41. Zarkesh-Esfahani H, Pockley AG, Wu Z, Hellewell PG, Weetman AP, Ross RJ. Leptin indirectly activates human neutrophils via induction of TNF-alpha. J Immunol. 2004;172:1809-14. (Pubitemid 38116829)
42. Fitzpatrick E, Mitry RR, Quaglia A, Hussain MJ, DeBruyne R, Dhawan A. Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD. J Pediatr Gastroenterol Nutr. 2010;51:500-6.
43. Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol. 1999;194:6-11. (Pubitemid 29283971)